Page last updated: 2024-08-22

sodium tungstate(vi) and tacrolimus

sodium tungstate(vi) has been researched along with tacrolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guinovart, JJ; Murguia, JR; Rodriguez-Hernandez, CJ	1

Other Studies

1 other study(ies) available for sodium tungstate(vi) and tacrolimus

Article	Year
Anti-diabetic and anti-obesity agent sodium tungstate enhances GCN pathway activation through Glc7p inhibition. FEBS letters, 2012, Feb-03, Volume: 586, Issue:3 Topics: Amino Acids; Anti-Obesity Agents; Antineoplastic Agents; Drug Synergism; Food; Humans; Hypoglycemic Agents; Mutation; Protein Phosphatase 1; Protein Serine-Threonine Kinases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Tacrolimus; Triazoles; Tungsten Compounds	2012

Article

Year

Anti-diabetic and anti-obesity agent sodium tungstate enhances GCN pathway activation through Glc7p inhibition.

FEBS letters, 2012, Feb-03, Volume: 586, Issue:3

Topics: Amino Acids; Anti-Obesity Agents; Antineoplastic Agents; Drug Synergism; Food; Humans; Hypoglycemic Agents; Mutation; Protein Phosphatase 1; Protein Serine-Threonine Kinases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Tacrolimus; Triazoles; Tungsten Compounds

2012